NEXTGENOLOGY LTD

Company Registration Number:
08322057 (England and Wales)

Unaudited micro entity accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

NEXTGENOLOGY LTD

Contents of the Financial Statements

for the Period Ended 31 December 2022

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

NEXTGENOLOGY LTD

Company Information

for the Period Ended 31 December 2022




Director: Sarah J Aitken
Registered office: 20-22
Wenlock Road
London
England
N1 7GU
Company Registration Number: 08322057 (England and Wales)

NEXTGENOLOGY LTD

Directors' Report Period Ended 31 December 2022

The directors present their report with the financial statements of the company for the period ended 31 December 2022

Principal Activities

Scientific manuscript editing

Political and charitable donations

There were no political or charitable donations during this period

Company policy on the employment of disabled persons

It is the company’s policy to give employment to disabled persons wherever practicable

Directors

The directors shown below have held office during the whole of the period from 01 January 2022 to 31 December 2022
Sarah J Aitken

This report was approved by the board of directors on 30 September 2023
And Signed On Behalf Of The Board By:

Name: Sarah J Aitken
Status: Director

NEXTGENOLOGY LTD

Balance sheet

As at 31 December 2022


2022
£

2021
£
Called up share capital not paid: 0 0
Fixed Assets: 2,081 2,774
Current assets: 12,818 23,857
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 6,644 ) ( 11,714 )
Net current assets (liabilities): 6,174 12,143
Total assets less current liabilities: 8,255 14,917
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 8,255 14,917
Capital and reserves: 8,255 14,917

NEXTGENOLOGY LTD

Balance sheet continued

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 30 September 2023
And Signed On Behalf Of The Board By:

Name: Sarah J Aitken
Status: Director

The notes form part of these financial statements

NEXTGENOLOGY LTD

Footnotes to the Financial Statements

for the Period Ended 31 December 2022

  • 1. Employee Information

    Average number of employees: 1

NEXTGENOLOGY LTD

Footnotes to the Financial Statements

for the Period Ended 31 December 2022

  • 2. Off balance sheet disclosure

    No